Trial Profile
Clinical Trials Insight: 700030076
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 24 Jan 2008
Price :
$35
*
At a glance
- Drugs Auriclosene (Primary)
- Indications Staphylococcal infections
- Focus Therapeutic Use
- Sponsors NovaBay Pharmaceuticals
- 24 Jan 2008 New trial record.